| A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia V Lacronique, A Boureux, V Della Valle, H Poirel, CT Quang, ... Science 278 (5341), 1309-1312, 1997 | 1010 | 1997 |
| Maintenance therapy with thalidomide improves survival in patients with multiple myeloma M Attal, JL Harousseau, S Leyvraz, C Doyen, C Hulin, L Benboubker, ... Blood 108 (10), 3289-3294, 2006 | 873 | 2006 |
| Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials N Boissel, MF Auclerc, V Lhéritier, Y Perel, X Thomas, T Leblanc, ... Journal of Clinical Oncology 21 (5), 774-780, 2003 | 743 | 2003 |
| Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell … P Moreau, T Facon, M Attal, C Hulin, M Michallet, F Maloisel, JJ Sotto, ... Blood, The Journal of the American Society of Hematology 99 (3), 731-735, 2002 | 697 | 2002 |
| Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support N Milpied, E Deconinck, F Gaillard, V Delwail, C Foussard, C Berthou, ... New England Journal of Medicine 350 (13), 1287-1295, 2004 | 486 | 2004 |
| Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia C Preudhomme, J Guilhot, FE Nicolini, A Guerci-Bresler, F Rigal-Huguet, ... New England Journal of Medicine 363 (26), 2511-2521, 2010 | 475 | 2010 |
| Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 … F Garban, M Attal, M Michallet, C Hulin, JH Bourhis, I Yakoub-Agha, ... Blood 107 (9), 3474-3480, 2006 | 458 | 2006 |
| Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly … P Moreau, H Avet-Loiseau, T Facon, M Attal, M Tiab, C Hulin, C Doyen, ... Blood, The Journal of the American Society of Hematology 118 (22), 5752-5758, 2011 | 376 | 2011 |
| Essential role for the p110δ isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia P Sujobert, V Bardet, P Cornillet-Lefebvre, JS Hayflick, N Prie, F Verdier, ... Blood 106 (3), 1063-1066, 2005 | 348 | 2005 |
| Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT … M Hunault, JL Harousseau, M Delain, M Truchan-Graczyk, JY Cahn, ... Blood 104 (10), 3028-3037, 2004 | 290 | 2004 |
| Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome–positive ALL P Rousselot, MM Coudé, N Gokbuget, C Gambacorti Passerini, S Hayette, ... Blood, The Journal of the American Society of Hematology 128 (6), 774-782, 2016 | 267 | 2016 |
| BAFF‐modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab‐treated patients with Sjögren's syndrome JO Pers, V Devauchelle, C Daridon, B Bendaoud, RL Berre, A Bordron, ... Arthritis & Rheumatism 56 (5), 1464-1477, 2007 | 242 | 2007 |
| High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized … E Gyan, C Foussard, P Bertrand, P Michenet, S Le Gouill, C Berthou, ... Blood, The Journal of the American Society of Hematology 113 (5), 995-1001, 2009 | 209 | 2009 |
| Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings and outcome. A collaborative study of the Groupe Francais de … GF de Cytogénétique Hématologique Blood 87, 3135-3142, 1996 | 208 | 1996 |
| A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous … F Witz, A Sadoun, MC Perrin, C Berthou, J Briere, JY Cahn, B Lioure, ... Blood, The Journal of the American Society of Hematology 91 (8), 2722-2730, 1998 | 204 | 1998 |
| High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study … P Colombat, A Lemevel, P Bertrand, V Delwail, P Rachieru, A Brion, ... Bone marrow transplantation 38 (6), 417-420, 2006 | 180 | 2006 |
| Imatinib is effective in children with previously untreated chronic myelogenous leukemia in early chronic phase: results of the French national phase IV trial F Millot, A Baruchel, J Guilhot, A Petit, T Leblanc, Y Bertrand, F Mazingue, ... J Clin Oncol 29 (20), 2827-2832, 2011 | 177 | 2011 |
| Infectious diseases in the first year of life, perinatal characteristics and childhood acute leukaemia JD Silva, Y Perel, F Méchinaud, E Plouvier, V Gandemer, P Lutz, ... British journal of cancer 90 (1), 139-145, 2004 | 173 | 2004 |
| Thalidomide in patients with advanced multiple myeloma: a study of 83 patients--report of the Intergroupe Francophone du Myélome (IFM). I Yakoub-Agha, M Attal, C Dumontet, V Delannoy, P Moreau, C Berthou, ... The Hematology Journal: the Official Journal of the European Haematology …, 2002 | 170* | 2002 |
| Combination of quinine as a potential reversing agent with mitoxantrone and cytarabine for the treatment of acute leukemias: a randomized multicenter study E Solary, B Witz, D Caillot, P Moreau, B Desablens, JY Cahn, A Sadoun, ... | 145 | 1996 |
